Latest news with #RickyChiu
Bloomberg
21-05-2025
- Business
- Bloomberg
Covid Cases Spike in Hong Kong, Singapore
Phase Scientific CEO & founder Ricky Chiu discusses the recent Covid-19 spikes in Hong Kong, Singapore and how that has affected the company's business with Bloomberg's Yvonne Man and David Ingles. (Source: Bloomberg)
Bloomberg
21-05-2025
- Business
- Bloomberg
Covid Testing Demand Surges as Cases Spike Across Asia
Demand for Covid tests is increasing in Hong Kong as cases surge in recent weeks, according to the top executive of diagnostic kit-maker Phase Scientific International Ltd. The Hong Kong-based company, which is a major provider of Covid testing kits in Asia Pacific, has seen business gain because of the Covid wave across Asia, Chief Executive Officer Ricky Chiu said in an interview with Bloomberg TV.
Yahoo
21-05-2025
- Business
- Yahoo
Covid testing demand surges as cases spike across Asia
(Bloomberg) – Demand for Covid tests is increasing in Hong Kong as cases surge in recent weeks, according to the top executive of diagnostic kit-maker Phase Scientific International. The Hong Kong-based company, which is a major provider of Covid testing kits in Asia Pacific, has seen business gain because of the Covid wave across Asia, Chief Executive Officer Ricky Chiu said in an interview with Bloomberg TV. Health authorities in densely-populated Hong Kong and Singapore have warned that Covid-19 cases are spiking, while data from the Chinese Center for Disease Control and Prevention showed the Covid wave in China is on track reach last year's summer peak. Shares of Covid test kit and drug makers in Asia have risen tracking a surge in infections. 'Covid is a seasonal thing,' said Chiu, adding that 'definitely there is a spike in the business.' Phase Scientific has also seen growth in its non-Covid testing business due to the pandemic, which made more people aware of the importance of at-home testing for other diseases, Chiu said. The company has developed the world's first urine-based human papillomavirus test, and is planning to expand that business globally. The company raised $34 million in Series A financing this week, the largest such round in Asia's diagnostic technology sector since 2019. (Updates with more details.) More stories like this are available on ©2025 Bloomberg L.P.
Business Times
21-05-2025
- Business
- Business Times
Covid-19 testing demand surges as cases spike across Asia
[BEIJING] Demand for Covid-19 tests is increasing in Hong Kong as cases surge in recent weeks, according to the top executive of diagnostic kit maker Phase Scientific International. The Hong Kong-based company, which is a major provider of Covid-19 testing kits in Asia Pacific, has seen business gain because of the Covid-19 wave across Asia, chief executive officer Ricky Chiu said. Health authorities in densely-populated Hong Kong and Singapore have warned that Covid-19 cases are spiking, while data from the Chinese Center for Disease Control and Prevention showed the Covid-19 wave in China is on track reach last year's summer peak. Shares of Covid-19 test kit and drug makers in Asia have risen tracking a surge in infections. 'Covid-19 is a seasonal thing,' said Chiu, adding that 'definitely there is a spike in the business'. Phase Scientific has also seen growth in its non-Covid-19 testing business due to the pandemic, which made more people aware of the importance of at-home testing for other diseases, Chiu said. The company has developed the world's first urine-based human papillomavirus test, and is planning to expand that business globally. The company raised US$34 million in Series A financing this week, the largest such round in Asia's diagnostic technology sector since 2019. BLOOMBERG
South China Morning Post
20-05-2025
- Health
- South China Morning Post
Hong Kong's Phase Scientific gets US$34 million to advance test for cancer risk factor HPV
Hong Kong's Phase Scientific International (PSI) has raised US$34 million from private investors to further develop a non-invasive test for human papillomavirus (HPV), a major cause of cervical cancer. Advertisement The test developed by the Hong Kong Science and Technology Park-based company, best known as a provider of COVID-19 tests during the pandemic, was the world's first urine-based HPV test, it said in a statement on Tuesday. Founder and CEO Ricky Chiu Yin-to said the company aimed to commercialise a home collection kit after the completion of a large-scale clinical study next year, which was expected to confirm favourable results the test had obtained so far. 'The market potential is huge because urine sampling is non-invasive and easy to do, which will help raise the compliance rate on regular testing,' he said. Some 95 per cent of cervical cancer is caused by persistent HPV infection of the cervix, according to the WHO. Advertisement PSI had overcome technical barriers for using urine as a medical sampling medium through a patented technology that concentrates and purifies urine samples, Chiu said.
